Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems Inc., a Canadian life sciences company, is set to release its Q2 financial results for fiscal 2024 before the markets open on May 15, 2024, followed by a webinar to discuss the outcomes with top executives. The company, known for producing biological products for human health that support the global diagnostics industry, has seen its annualized revenues approach C$ 2.0 million per month. Interested parties can join the webinar through various online platforms or arrange telephone participation.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
